What is the level of pain associated with a facial cheek skin graft in a typical adult patient with no significant underlying medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pain Associated with Facial Cheek Skin Grafts

Direct Answer

Pain from a facial cheek skin graft is typically minimal to mild because the graft recipient site itself has limited pain, though any donor site (if used) will be the primary source of significant postoperative discomfort.

Understanding the Pain Sources

The question conflates two distinct pain experiences that must be separated:

Recipient Site Pain (The Cheek Graft Itself)

  • Facial cheek reconstruction with skin grafts produces minimal pain at the recipient site because the grafted tissue is initially denervated and the underlying wound bed has limited sensory innervation 1
  • Full-thickness skin grafts to the cheek are commonly performed as outpatient procedures, indicating low expected pain levels 1
  • In a retrospective review of 422 cheek reconstructions, full-thickness skin grafting represented 8% of cases with minimal reported pain-related complications 1

Donor Site Pain (Where Graft is Harvested)

  • Donor site pain is reported as one of the most distressing symptoms during the early postoperative period and is typically more significant than recipient site pain 2
  • Split-thickness skin graft donor sites produce moderate to severe pain in the immediate postoperative period, with visual analog scale (VAS) scores averaging 6.9/10 without intervention 3
  • Pain at donor sites decreases significantly over the first 4-5 days postoperatively 4

Pain Management Algorithm

For Recipient Site (Cheek) Pain

First-line therapy:

  • Acetaminophen 1000mg scheduled every 6 hours (maximum 4g/day) 5
  • NSAIDs around-the-clock if no contraindications exist 5

Breakthrough pain only:

  • Immediate-release opioids at 10-20% of 24-hour requirement, not scheduled 5
  • Prophylactic laxatives must be prescribed with any opioid use 5

For Donor Site Pain (If Applicable)

Recommended interventions include:

  1. Local anesthetic infiltration: Subcutaneous injection of adrenaline-lidocaine at the donor site provides effective pain control 2

  2. Ice application: Apply cold ice packs wrapped in gauze for 10 minutes to the donor site, which significantly reduces pain scores from VAS 6.9 to 1.1 (p<0.001) 4, 3

  3. Topical agents: Lidocaine or bupivacaine applied to the donor site 2

  4. Advanced dressings: Hydrocolloid- and polyurethane-based wound dressings with fibrin sealant reduce donor site pain 2

Procedure-Related Pain Management

For the surgical procedure itself:

  • Local anesthetics with epinephrine (1:100,000 to 1:200,000) provide effective anesthesia for facial procedures 6
  • Anxiolytics should be administered preemptively when feasible 7, 6
  • Detailed preprocedure education helps patients tolerate procedures better 7, 8, 6

Critical Clinical Pitfalls

  • Do not assume vital signs correlate with pain intensity - hemodynamic changes are not valid correlates of procedural or postoperative pain 9
  • Do not neglect donor site pain management - this is typically the primary source of patient distress, not the recipient site 2, 10
  • Avoid relying solely on opioids - multimodal analgesia combining acetaminophen, NSAIDs, and local techniques is superior 5, 2
  • Do not withhold anticoagulation - in the cheek reconstruction series, no hematomas occurred despite patients continuing anticoagulation 1

Expected Pain Timeline

  • Days 1-3: Peak pain intensity at donor sites (if present), minimal pain at cheek recipient site 4, 3
  • Days 4-5: Significant decrease in donor site pain, approaching baseline 4
  • Day 8-12: Complete epithelialization of donor sites with resolution of pain 3

References

Research

Simplifying cheek reconstruction: a review of over 400 cases.

Plastic and reconstructive surgery, 2012

Research

Treating pain on skin graft donor sites: Review and clinical recommendations.

The journal of trauma and acute care surgery, 2017

Research

Banana leaf dressing for skin graft donor areas.

Burns : journal of the International Society for Burn Injuries, 2003

Guideline

Persistent Postsurgical Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Genital Nerve Block for Adult Genital Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Related Questions

Is it normal to have a significant amount of crusted blood around a skin graft bolster in the post-operative period?
What are the potential post-operative complications and management strategies for a patient who has undergone a skin graft procedure?
What is the safest topical antibiotic and dosing regimen to prevent infection without impairing graft take in a patient undergoing split‑thickness or full‑thickness skin graft?
Is it safe to use an ice pack on a post-catheterization (cath) wrist site?
What are the contraindications for paracentesis in patients with bleeding disorders, liver disease, or those on anticoagulant therapy, such as warfarin (coumarin) or heparin?
What is the initial management for a patient suspected of having ileus (ileus) versus partial small bowel obstruction (SBO)?
What is the role of pruning in neuroplasticity, particularly in conditions such as autism spectrum disorders or after a brain injury, and how can it be facilitated or targeted for therapeutic interventions?
What is the appropriate autoimmune workup for a patient presenting with uveitis?
What is the recommended treatment plan for a patient with advanced osteoarthritis and potential labral tear of the right hip, characterized by femoral-acetabular dysplasia, CAM (Cervical-Acetabular Morphology) lesion, and degenerative changes in the acetabular cartilage, with minimal synovitis and joint fluid, and no evidence of acute fracture, subluxation, or avascular necrosis?
What medications or supplements are affected in a patient with a CYP2D6 (cytochrome P450 2D6) variation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.